Author:
Burger Ulrike L.,Chang Maximilian P.,Nagoshi Makoto,Goedegebuure Peter S.,Eberlein Timothy J.
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Rosenberg SA, Spiess P, Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.Science 1986;233:1318–21.
2. Spiess PJ, Yang JC, Rosenberg SA. In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2.J Natl Cancer Inst 1987;79:1067–75.
3. Burger UL, Chang MP, Goedegebuure PS, Eberlein TJ. Tumor eradication by tumor-infiltrating lymphocytes and rIL-2 requires the recruitment of host CD8+ T cells.Surgery 1995;117:325–33.
4. Massaro AF, Schoof DD, Rubinstein A, Zuber M, Leonard-Vidal FJ, Eberlein TJ. Solid-phase anti-CD3 antibody activation of murine tumor-infiltrating lymphocytes.Cancer Res 1990;50:2587–92.
5. Goedegebuure PS, Douville L, Li H, et al. Adoptive immunotherapy with tumor-infiltrating lymphocytes and interleukin-2 in patients with metastatic malignant melanoma and renal cell carcinoma.J Clin Oncol 1995;13:1939–49.
Cited by
10 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献